BRAT1 Antilichaam / BRCA1 geassocieerde ATM activator 1

Western blot: 1:500-1:2000, Immunocytochemistry/Immunofluorescence: 1:50-1:200, Immunoprecipitation: 1:50, Flow Cytometry: 1:50

Q6PJG6

Human

A synthesized peptide derived from human BRAT1 was used as the immunogen for the BRAT1 antibody.

29B86

WB, ICC, IF, IP, FACS

Affinity-chromatography

Liquid

Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5 mg/mL BSA.

This BRAT1 antibody is available for research use only.

Store the BRAT1 antibody at -20°C.

Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5 mg/mL BSA

Optimal dilution of the BRAT1 antibody should be determined by the researcher.

Immunoprecipitation analysis using the antibody at 1:50 dilution. Western blot probed with anti-BRAT1 shows a major band at ~75 kDa, lower than the predicted ~88 kDa, consistent with the known anomalous migration of BRAT1 due to its compact structure and partial N-terminal processing.